Photys Therapeutics is a proprietary chimeric small molecules platform company, developing a new class of medicines for precise control of protein function.
Location: United States, Massachusetts, Waltham
Employees: 11-50
Total raised: $75M
Founded date: 2021
Investors 5
| Date | Name | Website |
| 18.05.2023 | MPM Capita... | mpmcapital... |
| 30.03.2022 | 8VC | 8vc.com |
| 07.09.2022 | MRL Ventur... | mrlv.com |
| 05.09.2022 | Arkin Hold... | arkinholdi... |
| 10.11.2023 | Ono Ventur... | onoventure... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.09.2022 | Series A | $75M | - |
Mentions in press and media 5
| Date | Title | Description | Source |
| 09.09.2022 | Photys Therapeutics Debuts with $75 Million Series A Funding... | - | mpmcapital... |
| 08.09.2022 | Photys Therapeutics Secures $75M Series A | BOSTON, MA, Photys Therapeutics today announced a $75 million Series A financing round. >> ... | vcnewsdail... |
| 08.09.2022 | Photys Therapeutics raises $75M in Series A funds to control... | A new drug company emerged from stealth on Thursday. Photys Therapeutics debuted with a $75 million... | medcitynew... |
| 08.09.2022 | Photys Therapeutics Raises $75M in Series A Funding | Photys Therapeutics, a Boston, MA-based developer of phosphorylation-inducing chimeric small molecul... | finsmes.co... |
| - | Photys Therapeutics | “Photys Therapeutics is a proprietary chimeric small molecules platform company, developing a new cl... | fastfounde... |